Home
Lilly & Co Eli reported a 11.9% stake in Aktis Oncology AKTS · 6,344,114 sh
Trade details
- Type
- 5% stake report
- Report
- 13D
- Stake
- 11.9%
- Last report
- First report
- Shares held
- 6,344,114 sh
- Class
- Common Stock, $0.0001 par value per share
- Stock
- Aktis Oncology AKTS
- Holder
- Lilly & Co Eli
- Event date
- 26/01/12
- Filed
- 26/01/15
First 5%+ report · 11.9% stake
Aktis Oncology trades, last 26 weeks
What else happened in Aktis Oncology around then
Filed or reported within 30 days of the trade day · 25/12/13~02/11Lilly & Co Eli's other 5% stake reports
- Lilly & Co Eli
5% stakeScribe Therapeutics
5% stakeScribe Therapeutics
SCTX
7.3% stake
1,388,161 sh
7.3% stake
Filed 07/30
